Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial - Takeaways - MDSpire

Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial

  • By

  • Karen H. Lu

  • Barbara M. Norquist

  • Gary B. Chisholm

  • Christine B. Peterson

  • Kara C. Long Roche

  • Jamie N. Bakkum-Gamez

  • Iris L. Romero

  • Colleen Feltmate

  • Douglas A. Levine

  • Sarah Kim

  • Andrea R. Hagemann

  • Jeanne Carter

  • Martha Hickey

  • Jamie Crase

  • Kathleen Gavin

  • Deborah Polinsky

  • Alan D. D’Andrea

  • Denise R. Nebgen

  • Elizabeth M. Swisher

  • July 7, 2026

  • 0 min

Share

  • 1

    Genetic testing has increased awareness of high ovarian cancer risk due to BRCA1, BRCA2, and other pathogenic variants.

  • 2

    Risk-reducing salpingo-oophorectomy (RRSO) is the only evidence-based intervention for high-risk individuals to prevent ovarian cancer.

  • 3

    Interval salpingectomy with delayed oophorectomy (ISDO) aims to reduce ovarian cancer risk while delaying surgical menopause.

  • 4

    The Women Choosing Surgical Prevention trial compares sexual function and menopausal symptoms in high-risk individuals undergoing ISDO or RRSO.

  • 5

    Participants in the trial were premenopausal or perimenopausal individuals aged 30 to 50 years with documented pathogenic variants.

Original Source(s)

Related Content